Navigation Links
New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease
Date:10/31/2011

ct, most commonly at the end of the small intestine (the ileum) and beginning of the large intestine (the colon).   If not effectively treated, it may result in the need for surgery and hospitalization. Crohn's disease has been estimated to affect as many as half a million Americans.  People with Crohn's can experience an ongoing cycle of flare-up and remission throughout their lives.

About Cimzia

Certolizumab pegol is the only PEGylated anti-TNF (Tumor Necrosis Factor).  It has a high affinity for human TNF-alpha, selectively neutralizing the pathophysiological effects of TNF-alpha.  Over the past decade, TNF-alpha has emerged as a major target of basic research and clinical investigation.  This cytokine plays a key role in mediating pathological inflammation, and excess TNF-alpha production has been directly implicated in a wide variety of diseases.  The U.S. Food and Drug Administration (FDA) has approved certolizumab pegol for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderate to severe active disease who have had an inadequate response to conventional therapy.  It is also approved for the treatment of adults with moderately to severely active rheumatoid arthritis.  Certolizumab pegol was approved in Switzerland for induction of a clinical response and for the maintenance of a clinical response and remission in patients with active Crohn's disease who have not responded adequately to conventional treatment in September 2007.

Please visit www.cimzia.com for full prescribing information for CIMZIA®.

Important Safety Information

Risk of Serious Infections and Malignancy

Patients treated with CIMZIA are at an increased risk for developing serious infections that may lead to hospitalization or death.  Most patients who developed these infections we
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients
2. Cimzia® (certolizumab pegol) Data Showed Broad and Rapid Relief From Burden of Symptoms In Rheumatoid Arthritis Patients
3. New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
4. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
5. UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohns Disease
6. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
7. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
8. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
9. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
10. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
11. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 2015  DICOM Grid,  the #1 medical image ... recognized as a semifinalist for a Minnie award ... awards are sponsored by Auntminnie.com, a comprehensive community ... medical imaging industry.  Since 1999, the "Minnies" have ... the contributions of their peers. Nominations are made ...
(Date:8/31/2015)... -- Ascendant Solutions, Inc. (Pink Sheets: ASDS ) ("Ascendant" ... Dougherty,s Holdings, has acquired Springtown Drug (" Springtown ... Springtown, Texas , just north of Fort ... has provided retail prescriptions, healthcare products and gifts for ... The Springtown pharmacy ...
(Date:8/31/2015)... 2015 With increasing clinical applications, the ... rise in active partnerships. The primary reason for ... quantitate CD4 cell markers in human immunodeficiency virus ... New analysis from Frost ... Market ( http://www.frost.com/nf0e ), finds the market earned ...
Breaking Medicine Technology:DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 2Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4
... -- Keryx,Biopharmaceuticals, Inc. today announced that abstracts ... selected for,publication or presentation during the poster ... American Diabetes Association (ADA) 67th,Annual Scientific Sessions ... in Chicago, Illinois. , Copies of these ...
... 21, 2007 - The,PromegaExpress(TM) on-site stocking program just ... of on-site appliances. This,latest addition serves as great ... areas when space is at a premium,but immediate ... The,mid-sized cabinet can also be stacked with another ...
Cached Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 2Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 3Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 4
(Date:8/31/2015)... Sierra Madre, CA (PRWEB) , ... August 31, ... ... partnered wound center management, recently opened registration for the company’s second Introduction to ... will be held October 15-18, 2015 aboard the Queen Mary Hotel in Long ...
(Date:8/31/2015)... ... August 31, 2015 , ... Women’s Excellence ... , Starting September 1st they are offering pre and postnatal fitness classes ... Body, Healthy Baby." , More information can be found at 248-601-6683. , Women’s ...
(Date:8/31/2015)... FL (PRWEB) , ... August 31, 2015 , ... The ... quality healthcare to Veterans residing across southwest Florida by hiring more doctors and nurses ... the list of expanded services. , In early July, Dr. Anthony Jabre was selected ...
(Date:8/31/2015)... ... August 31, 2015 , ... Garden State ... 2008, the result of a merger of five of the busiest urology practices ... could provide more cost-effective and higher quality care than they did individually. ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Dr. Paul ... “NJ Top Doc.” , At OSSMC, Dr. Kovatis treats all surgical and non-surgical disorders ... traumatic injuries to the entire musculoskeletal system, excluding the spine. , Dr. Paul Kovatis ...
Breaking Medicine News(10 mins):Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2
... Making preschool available to all children age three and ... say three Yale scholars who have won the 2008 ... change would improve the school-readiness of the nations young ... high school dropout rate, reduce crime and boost the ...
... study of young women with heart attacksVIRGO (Variation in ... patients)was recently launched at Yale School of Medicine with ... This is the first study to focus on this ... Health Associate Professor Judith Lichtman, co-principal investigator of the ...
... received a renewal of a $1.5 million grant from the ... abilities of elderly drivers. The study is the first of ... natural driving environments. , Under the direction of principal ... Memory Disorders Center at Rhode Island Hospital, 150 older drivers ...
... certify retailers, utilities, financial institutions, ... healthcare organizations and others, ATLANTA, Dec. 18 ... over 2,000 clients, has been,designated as a Qualified Security Assessor ... PCI Security Standards,Council, created by the five major credit card ...
... Urologists Have Performed 15 Different, ... Procedures Include,Single Port Nissen Fundoplication, Colectomy, Prostatectomy ... Novare Surgical Systems,announced the successful completion ... RealHand HD instruments. These ,hidden scar, procedures,require ...
... few years much ballyhooed lunch hour and weekend ... are expected to pursue more reliably effective approaches ... Spiegel, MD, chief of facial plastic and reconstructive ... Boston Medical Center, people are frustrated and ...
Cached Medicine News:Health News:Yale launches landmark VIRGO study of young women with heart disease 2Health News:SecureWorks Designated as a Qualified Security Assessor for PCI Audits 2Health News:Novare Announces Completion of 100th Single Port Laparoscopic Procedure Using RealHand(R) High Dexterity (HD) Instruments 2Health News:Novare Announces Completion of 100th Single Port Laparoscopic Procedure Using RealHand(R) High Dexterity (HD) Instruments 3Health News:Significant changes in plastic surgery expected in 2008 2Health News:Significant changes in plastic surgery expected in 2008 3
Combination heat and moisture exchanger and bacterial/viral filters for Anesthesia and Respiratory applications....
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to ...
Indications For Usage: ,Pediatric (recommended tidal volume 70-250ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intend...
... The Portex® Thermovent® T helps provide protection to ... is small and extremely lightweight making it ideal ... With a high rate of heat and moisture ... retention., ,All HMEs and filters have ISO ...
Medicine Products: